Telesat (TSAT) Q2 2026 Earnings Call Transcript

Telesat reported Q2 2026 consolidated revenue of $79M (-25% YoY) and a net loss of $559M, including a $475M non-cash fair value loss on Telesat Lightspeed warrants. At the same time, Lightspeed guidance was raised to $1.3B–$1.5B for 2026 (vs. prior $1.0B–$1.2B) alongside a $2.7B (15-year) Canadian ESCAPE contract and expansion to a fully funded 225-satellite constellation (from 156). GEO revenue fell 26% YoY to $78M, while adjusted EBITDA declined 62% YoY to $22M, partly tied to $14M in debt refinancing costs; management also reiterated GEO guidance of $300M–$320M revenue and $210M–$230M adjusted EBITDA (ex-refinancing).

Analysis

This is a backlog-positive, equity-negative print. The market will want to price the headline contract and government linkage as a rerating event, but the more important mechanism is that the new work increases execution burden and capex before the network is generating meaningful service revenue. That means incremental EBITDA is still a long-dated story, while refinancing, currency, and launch/ground-segment spending remain immediate claims on the capital structure.

The cleaner winner is MDA/MDALF, not TSAT. Telesat’s accelerated satellite build and identity of the additional satellites implies more value leakage to the manufacturing and integration layer than to equity holders, because the cash economics are being pulled forward into suppliers while the revenue take-rate stays back-ended. The bigger second-order effect is competitive: sovereign and defense demand validates the category, but it also normalizes mixed-orbit, multi-vendor architectures that should benefit infrastructure providers and weaken the notion that TSAT has a durable, closed ecosystem moat.

The contrarian mistake is to treat backlog as liquidity. A lot of this pipeline is milestone-heavy, contingent, or tied to future delivery; meanwhile the C-band cash is delayed and conditional, and the warrant mark-up is non-cash. Over the next 1-3 months the real catalyst is the debt outcome; over 6-18 months it is whether TSAT can convert defense enthusiasm into free cash flow rather than just a larger, more complex capex program. The thesis breaks if they announce a truly consensual refi with minimal dilution and show a faster-than-expected path to commercial cash generation, but absent that, the setup still looks structurally fragile.

Key Decisions for Investors

• Do not buy TSAT common here; treat any post-earnings strength as an opportunity to reduce exposure ahead of the refinancing catalyst over the next 1-3 months.
• Pair trade: long MDALF / short TSAT for 3-6 months. Thesis: MDA captures the manufacturing uplift from a larger constellation, while TSAT carries the financing and execution risk.
• If TSAT rallies on headline backlog enthusiasm, consider buying 3-6 month TSAT put spreads as a convex hedge against a refinancing or dilution surprise.
• Set a watch item on the debt negotiation timeline and financing terms; thesis is weakened if management secures a consensual refi without equity dilution and keeps 2028 launch/service timing intact.
• Avoid chasing the perceived C-band upside; the cash is contingent and too delayed to underwrite near-term equity value.